Sep
3
2010
Abbott Laboratories has called a halt to the sale of its European flu-vaccine unit because of a dissapointing run of initial bids, The Wall Street Journal reported. Abbott announced it would be selling the business in June and recieved interest from four or five bidders, but offers did not top €500 million ($640 million), which [...]
no comments | tags: Abbott, abbott laboratories, Business, flu vaccine, Halts, Main Category, Vaccine | posted in financial
Sep
3
2010
Abbott Laboratories has called a halt to the sale of its European flu-vaccine unit because of a dissapointing run of initial bids, The Wall Street Journal reported. Abbott announced it would be selling the business in June and recieved interest from four or five bidders, but offers did not top €500 million ($640 million), which [...]
no comments | tags: Abbott, abbott laboratories, Business, flu vaccine, Halts, Main Category, Vaccine | posted in financial
Twitter
Facebook